Sanjay J. Mathew, MD, vice chair for research at Baylor College of Medicine, will share the top 5 things that mental health clinicians should know about therapy with ketamine and esketamine at this year’s...
Previous studies have shown that short-term use of esketamine is effective for improving outcomes in patients with treatment-resistant depression, but little is known about its effectiveness in the...
Timothy J Wilt, MD, MPH, from the Clinical Guidelines Committee of the ACP, discussed guideline-recommended pharmacologic and nonpharmacologic treatments for major depressive disorder in adults at the ACP...
The FDA has approved a new treatment option that is the first drug approved by the FDA specifically for the treatment of postpartum depression in adult women.
The FDA Psychopharmacologic Drug Advisory Committee and Drug Safety and Risk Management Advisory Committee jointly voted on the benefit-risk profile of esketamine nasal spray for the treatment of adults...
Although many studies have examined the effects of cannabis use during adolescence on development of psychosis, little is known about its effects on mood and suicidality in young adulthood, according to the...
Because of the increasing popularity of electronics among the nation’s youth, experts aimed to assess the effects of screen time on the risk of depression in US children and adolescents. Their findings were...
